4-Benzoylmorpholine

Product Overview & Core Commercial Positioning

In high-end pharmaceutical synthesis where impurity tolerance is minimal, our 4-Benzoylmorpholine (commonly utilized as a halogen-free amide building block) serves as the cornerstone for overcoming compliance barriers. This molecule features a stable amide linkage connecting the morpholine ring and benzoyl group, endowing it with superior conformational stability and reaction selectivity in cross-coupling reactions. As a critical precursor for synthesizing Sartan antihypertensives and side chains of novel CNS analgesics, this product completely eliminates halogen presence at the molecular source. It is tailored for leading innovative pharmaceutical companies and CDMO platforms that prioritize streamlined downstream purification and rigorous QA audit compliance.

Product Specifications

Industry Pain Points & Our Process Advantages

Conventional commercial 4-Benzoylmorpholine typically relies on the cost-effective benzoyl chloride route, inevitably leaving residual free chloride ions. These trace halogen impurities pose a significant risk to downstream manufacturers, frequently causing poisoning of expensive precious metal catalysts. Furthermore, traditional batch processing involving crude high-temperature heating induces thermal oxidation, resulting in substandard yellowed or darkened appearance.

To comprehensively address this industry challenge, we have abandoned traditional chlorinated raw materials in favor of a non-halogenated condensation process. From an engineering perspective, we implemented an efficient integrated bypass reactive distillation system. Leveraging rapid heat transfer and high-pressure differential separation technologies, we disrupt reaction equilibrium while minimizing the material's thermal history to the absolute minimum.

This fundamental process reconfiguration delivers direct commercial value: a crystal-clear water-white appearance and genuine zero-chlorine residue. By choosing our product, your R&D and production teams can eliminate cumbersome and loss-intensive decolorization and dehalogenation steps. This significantly extends the lifespan of expensive catalysts, mitigates compliance risks associated with heavy metal introduction at the source, and enhances the cost and quality competitiveness of your new drug projects.

Source Factory & Proprietary Continuous Flow Technology Advantages

As a source manufacturer, Ningbo Yinuo Chemicals Co., Ltd. possesses self-developed and designed pipeline-style continuous flow reaction equipment. We emphasize our technical strengths: superior batch-to-batch consistency and intrinsic safety. We are committed to establishing long-term strategic partnerships with trading companies and end-users.